Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 254 (2019-2020)

https://ontology.bommaritollc.com/id/01a0d567-814a-72d2-9051-fdefa8fd7af3

adms:identifier	mi-legislature-measure 2019-2020/SB/254
dcterms:temporal	Michigan Legislature, 2019-2020 session
enacted as	2020 PA 135
primary sponsor	Dale W. Zorn
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-SB-0254 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-SB-0254
schema:legislationChanges	MCL 333.16221 MCL 333.16221b
schema:legislationIdentifier	SB 254
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: controlled substances; requirement for opioid and benzodiazepine prescriptions to be electronically transmitted to pharmacies; provide for under certain circumstances. Amends secs. 16221 & 16221b of 1978 PA 368 (MCL 333.16221 & 333.16221b). TIE BAR WITH: SB 0248'19 , HB 4217'19en
schema:sponsor	Dale W. Zorn
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-SB-0254
skos:prefLabel	SB 254 (2019-2020)en